Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
Moderna(MRNA) stock is priced at $198.14, giving the company a market capitalization of 79.4B. It carries a P/E multiple of -24.40.
During the trading session on 2026-09-25, Moderna(MRNA) shares reached a daily high of $202.67 and a low of $192.50. At a current price of $198.14, the stock is +2.9% higher than the low and still -2.2% under the high.
Trading activity shows a volume of 13.91M, compared to an average daily volume of 16.24M.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $202.67 and a low of $22.28.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $202.67 and a low of $22.28.
MRNA News
...
Moderna’s (MRNA) shares recent popped up after positive news to its therapeutic cancer vaccine, an industry the company originally steered clear of out of fear...
Moderna, Inc. (NASDAQ:MRNA) shares are trending on Thursday night. Shares of the Massachusetts-based biotechnology and pharmaceutical company edged 0.087% high...
Analyst ratings
65%
of 26 ratingsMore MRNA News
Shares of Moderna (MRNA) were higher near noon after CEO Stephane Bancel said at the Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthca...
Moderna (NasdaqGS:MRNA) co-founder Bob Langer has joined Cellular Intelligence, a biotech focused on AI-driven drug discovery. The appointment includes work on...
Moderna (NASDAQ: MRNA) may finally have the catalyst investors have been waiting for beyond COVID. A successful Phase 3 melanoma study strengthens the case for...
Key Points Moderna surged 177% after promising results from one of its cancer-related mRNA clinical trials. Analysts remain largely on the fence, with two ana...
Moderna’s stock soared Monday after the biotech company confirmed that it will share highly anticipated Phase 3 data for its experimental mRNA-based cancer vacc...
Moderna Inc. (NASDAQ:MRNA) shares are surging Monday. The company announced three abstracts on its personalized cancer vaccine intismeran autogene were accepted...
Investing Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher A coveted Presidential Symposium slot at E...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.